Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy

As immune checkpoint inhibitor drugs are being used in the treatment of some cancers, unusual adverse events are being reported, labeled as immune-related adverse events. Various endocrinopathies related to immune-related adverse events have been described, among which hypoparathyroidism is exceedin...

Descripción completa

Detalles Bibliográficos
Autores principales: El Kawkgi, Omar M., Li, Dingfeng, Kotwal, Anupam, Wermers, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749243/
https://www.ncbi.nlm.nih.gov/pubmed/33367219
http://dx.doi.org/10.1016/j.mayocpiqo.2020.07.006
Descripción
Sumario:As immune checkpoint inhibitor drugs are being used in the treatment of some cancers, unusual adverse events are being reported, labeled as immune-related adverse events. Various endocrinopathies related to immune-related adverse events have been described, among which hypoparathyroidism is exceedingly rare. We report a case of hypoparathyroidism induced by immune checkpoint drugs, highlighting the need for awareness of this emerging complication.

Ejemplares similares